Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar htbrennan (47.55) Submitted: 8/9/2007 12:03:28 PM : Outperform Start Price: $22.53 AUXL Score: -8.59

CEO is a marketer,Exec. VP, Medimmune, rather than a Doc. Already have product and in late stage with new, so marketing is important.

Featured Broker Partners


Advertisement